Prenetics Global Stock (NASDAQ:PRE)


Chart

Previous Close

$4.60

52W Range

$2.85 - $7.84

50D Avg

$4.52

200D Avg

$5.02

Market Cap

$55.59M

Avg Vol (3M)

$15.72K

Beta

-0.21

Div Yield

-

PRE Company Profile


Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

HK

Employees

320

IPO Date

Jul 16, 2021

Website

PRE Performance


Peer Comparison


TickerCompany
MDXHMDxHealth SA
GTHGenetron Holdings Limited
DRIODarioHealth Corp.
QGENQiagen N.V.
ACRSAclaris Therapeutics, Inc.
FONRFONAR Corporation
NEOGNeogen Corporation
CSTLCastle Biosciences, Inc.
XGNExagen Inc.
BNRBurning Rock Biotech Limited
OLKOlink Holding AB (publ)